GenMark Diagnostics Stock News

Shares of GenMark Diagnostics (NASDAQ:GNMK) moved lower by 6.81% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were up 69.57% over the past year to

CARLSBAD, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial

The Global Influenza Diagnostics Market will grow by $ 1.32 bn during 2020-2024

GenMark Diagnostics, Inc (NASDAQ:GNMK), a key player in the molecular diagnostic solutions space, is set for stronger growth as the demand for diagnostic screening testing rise while its price decline

Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts. COVID-19 news flow continued to pour in,...

CARLSBAD, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the c

Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre

You'd think that, as biopharma companies close in on an effective vaccine to do battle against Covid-19, the days of widespread coronavirus tests are numbered. Not so fast, analysts say.

Unfortunately, investing is risky - companies can and do go bankrupt. But if you pick the right stock, you can make a...

Is (GNMK) Outperforming Other Medical Stocks This Year?

CARLSBAD, Calif., July 21, 2020 -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close.

Biodesix, Inc. a leader in lung cancer diagnostics, today announced the appointment of Jean Franchi and Hany Massarany to the company’s board of direc

Mike Cintolo is a leading growth stock expert and is the editor of Cabot Top Ten Trader. Highlights two companies (GNMK and NVTA) in the fast-growing market for molecular diagnostics and genetic testi

As of late, it has definitely been a great time to be an investor in GenMark Diagnostics.

The coronavirus has had a negative impact on most but as luck would have it, some companies have benefited from the viral outbreak. Along with those catering to the stay at home climate, healthcare co